Cancer Research Technology
Log in Register
Menu

Norrin Mutant [L61N/A63S] Vector

Invented by Tao-Hsin Chang from University of Oxford , E. Yvonne Jones from University of Oxford
Invented at University of Oxford

Info

Catalogue Number 152593
Vector Type pHLIgK-STR-8H-SUMO-1D4
Antigen/Gene or Protein Targets Human Norrin (Norrie Disease Protein, NDP)
Relevance Norrin (Norrie Disease Protein) is a cystine-knot like growth factor that can activate Wnt signalling by binding to Frizzled and another receptor protein called Lrp5/6. This group or ‘complex’ also includes molecules called glycosaminoglycans. The L61N/A63S mutant loses signalling activity and binding ability to Frizzled 4 receptor, but retains the interactions with co‐receptors of low density lipoprotein related protein 5/6 (Lrp5/6) and heparan sulphate proteoglycans (HSPGs). Wnt signalling regulates multiple processes including angiogenesis, inflammation, and tumorigenesis. In humans, mutations in the gene that encodes Norrin can cause a disease in which blood vessels in the eye fail to form correctly, which can result in blindness. However, it is not clear how Norrin activates Wnt signalling.
Research Area Neurobiology, Stem Cell Biology
Notes Plasmid is available in 10 ug aliquots.
Full sequence available on request.

Norrin recombinant protein expression and purification protocol
Norrin was expressed in HEK293T cells in the presence of 4 mM valproic acid, a histone deacetylase inhibitor (Backliwal et al., 2008), used to increase the expression level of secreted protein. The detailed expression protocol was described in our publication (Chang et al., 2015). Norrin conditioned media (500 ml) were dialyzed against 5L of PBS buffer plus 0.4 M NaCl for 24 hrs. The dialyzed media were adjusted to 20 mM Tris, pH 8.0 and 2.5 mM Imidazole, pH 7.5. Recombinant protein was further purified from the adjusted media by IMAC (TALON®Clontech), washed with 25 mM Tris, pH7.5, 0. 5 M NaCl, 0.02 M Imidazole, 10 % [w/v] Glycerol, and eluted in 25 mM Tris, pH7.5, 0.15 M NaCl, 0.5 M Imidazole. The purified sample was added CHAPS to 1% [w/v] and dialyzed against 25 mM Tris, pH 7.5, 1M NaCl, 10% [w/v] Glycerol, before treating with His-tagged HRV-3C protease to remove the SUMOtagged fusion protein. The untagged sample was further isolated by IMAC (collection of flow-through and wash with 25 mM Tris, pH7.5, 1 M NaCl, 0.01 M Imidazole, 1% [w/v] CHAPS) and purified by SEC (SEC, Superdex 200 10/300 GL High Performance, GE Healthcare Life Sciences) in 10 mM HEPES, pH 7.5, 0.7 M NaCl, 0.5% [w/v] CHAPS or 10 mM acetate buffer, pH 4.0, 0.5 M NaCl, 0.5% [w/v] CHAPS.

Recombinant protein can be stored in 10mM acetate buffer, pH 4.0, 0.5 M NaCl, 0.5% [w/v]CHAPS or in 10 mM HEPES, pH 7.5, 0.7 M NaCl, 0.5% [w/v] CHAPS.

Norrin (residues 25-133) L61N/A63S
KTDSSFIMDSDPRRCMRHHYVDSISHPLYKCSSKMVNLSRCEGHCSQASRSEPLVSFSTVLKQPFRSSCHCCRPQTSKLKALRLRCSGGMRLTATYRYILSCHCEECNS

References

There are 2 reference entries for this reagent.

View All References

References: 2 entries

Chang et al. 2015. Elife. 4:. PMID: 26158506.

Structure and functional properties of Norrin mimic Wnt for signalling with Frizzled4, Lrp5/6, and proteoglycan.

Europe PMC ID: 26158506


Add a reference

References: 2 entries

Chang et al. 2015. Elife. 4:. PMID: 26158506.

Structure and functional properties of Norrin mimic Wnt for signalling with Frizzled4, Lrp5/6, and proteoglycan.


Add a reference